Different ortho and para electronic effects on hydrolysis and cytotoxicity of diamino bis(Phenolato) "Salan" Ti(IV) complexes

Inorganic Chemistry

Volumn 50, Issue 3, 2011, Pages 1030-1038

  Peri, Dani ^a   Meker, Sigalit ^a   Manna, Cesar M ^a   Tshuva, Edit Y ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ORGANOMETALLIC COMPOUND; PHENOL DERIVATIVE; TITANIUM;

ARTICLE; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; COLON TUMOR; DRUG EFFECT; FEMALE; HUMAN; HYDROLYSIS; NEOPLASM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OVARY TUMOR; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; COLONIC NEOPLASMS; FEMALE; HUMANS; HYDROLYSIS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; NEOPLASMS; ORGANOMETALLIC COMPOUNDS; OVARIAN NEOPLASMS; PHENOLS; TITANIUM;

EID: 79951668191     PISSN: 00201669     EISSN: None     Source Type: Journal    
DOI: 10.1021/ic101693v     Document Type: Article

References (39)

1. Barnes, K. R.; Lippard, S. J. Met. Ions Biol. Syst. 2004, 42, 143-177.
2. Abu-Surrah, A. S.; Kettunen, M. Curr. Med. Chem. 2006, 13, 1337-1357.
3. Cepeda, V.; Fuertes, M. A.; Castilla, J.; Alonso, C.; Quevedo, C.; Perez, J. M. Anti-Cancer Agents Med. Chem. 2007, 7, 3-18.
4. Galanski, M.; Arion, V. B.; Jakupec, M. A.; Keppler, B. K. Curr. Pharm. Des. 2003, 9, 2078-2089.
5. Desoize, B. Anticancer Res. 2004, 24, 1529-1544.
6. Xu, G.; Cui, Y.B.;Cui, K.;Gou, S. H. Prog. Chem. 2006,18,107-113.
7. Ott, I.; Gust, R. Arch. Pharm. Chem. Life Sci. 2007, 340,117-126.
8. Bruijnincx, P. C. A.; Sadler, P. J. Curr. Opin. Chem. Biol. 2008, 12, 197-206.
9. Jakupec, M. A.; Galanski, M.; Arion, V. B.; Hartinger, C. G.; Keppler, B. K. Dalton Trans. 2008, 183-194.
10. Köpf-Maier, P.; Kopf, H. Chem. Rev. 1987, 87, 1137-1152.
11. Köpf-Maier, P.; Kopf, H. Struct. Bonding (Berlin) 1988, 70, 103-185.
12. Keppler, B. K.; Friesen, C.; Moritz, H. G.; Vongerichten, H.; Vogel, E. Struct Bonding (Berlin) 1991, 78,97-127.
13. Christod oulou, C. V.; Eliopoulos, A. G.; Young, L. S.; Hodgkins, L.; Ferry, D. R.; Kerr, D. J. Br. J. Cancer 1998, 77, 2088-2097.
14. Caruso, F.; Rossi, M.; Pettinari, C. Expert Opin. Ther. Pat. 2001, 11, 969-979.
15. Meléndez, E. Crit. Rev. Oncol. Hematol. 2002, 42, 309-315.
16. Caruso, F.; Rossi, M. Mini-Rev. Med. Chem. 2004, 4,49-60.
17. Kelter, G.; Sweeney, N. J.; Strohfeldt, K.; Fiebig, H.-H.; Tacke, M. Anti-Cancer Drugs 2005, 16, 1091-1098.
18. Abeysinghe, P. M.; Harding, M. M. Dalton Trans. 2007, 3474-3482.
19. Strohfeldt, K.; Tacke, M. Chem. Soc. Rev. 2008, 37, 1174-1187.
20. Toney, J. H.; Marks, T. J. J. Am. Chem. Soc. 1985, 107, 947-953.
21. Schilling, T.; Keppler, K. B.; Heim, M. E.; Niebch, G.; Dietzfelbinger, H.; Rastetter, J.; Hanauske, A. R. Invest. New Drugs 1995, 13,327-332.
22. Korfel, A.; Scheulen, M. E.; Schmoll, H. J.; Grundel, O.; Harstrick, A.; Knoche, M.; Fels, L. M.; Skorzec, M.; Bach, F.; Baumgart, J.; Sass, G.; Seeber, S.; Thiel, E.; Berdel, W. E. Clin. Cancer Res. 1998, 4, 2701-2708.
23. Caruso, F.; Massa, L.; Gindulyte, A.; Pettinari, C.; Marchetti, F.; Pettinari, R.; Ricciutelli, M.; Costamagna, J.; Canales, J. C.; Tanski, J.; Rossi, M. Eur. J. Inorg. Chem. 2003, 3221-3232.
24. Tshuva, E. Y.; Ashenhurst, J. A. Eur. J. Inorg. Chem. 2009, 2203-2218.
25. Shavit, M.; Peri, D.; Manna, C. M.; Alexander, J. S.; Tshuva, E. Y. J. Am. Chem. Soc. 2007, 129, 12098-12099.
26. Peri, D.; Meker, S.; Shavit, M.; Tshuva, E. Y. Chem. - Eur. J. 2009, 15, 2403-2415.
27. Tshuva, E. Y.; Peri, D. Coord. Chem. Rev. 2009, 253, 2098-2115.
28. Manna, C. M.; Tshuva, E. Y. Dalton Trans. 2010, 39, 1182-1184.
29. Immel, T. A.; Groth, U.; Huhn, T. Chem. - Eur. J. 2010, 16, 2775-2789.
30. Tshuva, E. Y.; Gendeziuk, N.; Kol, M. Tetrahedron Lett. 2001, 42, 6405-6407.
31. Whiteoak, C. J.; Britovsek, G. J. P.; Gibson, V. C.; White, A. J. P. Dalton Trans. 2009, 2337-2344.
32. Balsells, J.; Carroll, P. J.; Walsh, P. J. Inorg. Chem. 2001, 40, 5568-5574.
33. Chmura, A. J.; Davidson, M. G.; Jones, M. D.; Lunn, M. D.; Mahon, M. F.; Johnson, A. F.; Khunkamchoo, P.; Roberts, S. L.; Wong, S. S. F. Macromolecules 2006, 39, 7250-7257.
34. Gendler, S.; Segal, S.; Goldberg, I.; Goldschmidt, Z.; Kol, M. Inorg. Chem. 2006, 45, 4783-4790.
35. Groysman, S.; Sergeeva, E.; Goldberg, I.; Kol, M. Eur. J. Inorg. Chem. 2005, 2005, 2480-2485.
36. Yeori, A.; Groysman, S.; Goldberg, I.; Kol, M. Inorg. Chem. 2005, 44, 4466-4468.
37. As the polynuclear hydrolysis products are of low symmetry, the multiple signals of low integration in their 1H NMR spectra make it difficult to assign complete proton identity. Therefore, the percentage of cluster formed is estimated based on the percentage of free bis(phenol) ligand released.
38. Immel, T. A.; Debiak, M.; Groth, U.; Burkle, A.; Huhn, T. ChemMedChem 2009, 4, 738-741.
39. Kim, S. H.; Lee, J.; Kim, D. J.; Moon, J. H.; Yoon, S.; Oh, H. J.; Do, Y.; Ko, Y. S.; Yim, J. H.; Kim, Y. J. Organomet. Chem. 2009, 694, 3409-3417.